Citations

Showing 10 of 108104 citations.

Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer
Hurria, Arti , Allred, Jacob B., Cohen, Harvey Jay, Arsenyan, Anait, Jatoi, Aminah , Filo, Julie, Mandelblatt, Jeanne S. , Lafky, Jacqueline M., Kimmick, Gretchen , Burstein, Harold J. , Magrinat, Gustav , Barginear, Myra F., Muss, Hyman B. , Soto-Perez-de-Celis, Enrique , Ballman, Karla V. , Le‐Rademacher, Jennifer , Klepin, Heidi D. , Freedman, Rachel A. , Gralow, Julie R. , Wolff, Antonio C.

Mayo Clinic

Journal of the American Geriatrics Society | August 28, 2018 | Volume: 67 | Issue: 5 | Pages: 920-927

10.1111/jgs.15493 | PMID 30146695 Get It

Objectives To analyze self‐reported changes in physical function in older women with breast cancer receiving adjuvant chemotherapy. Design Secondary analysis of the Cancer and Leukemia Group B (CALGB) 49907 prospective randomized clinical trial. Setting CALGB institutions in the United States. Participants Women aged 65 and older with Stage I to III breast cancer enrolled in CALGB 49907 who had physical function data from before and after receipt of adjuvant chemotherapy (N=256; mean age 71.5, range 65–85). Measurements Participants were administered the physical function subscale of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire before chemotherapy, at the end of chemotherapy, and 12 months after chemotherapy initiation. Functional decline was defined as a more than 10‐point decrease from baseline at each time point. Resilience was defined as return to within 10 points of baseline. Multivariable regression was used to examine pretreatment characteristics associated with physical function changes. Results Of 42% of participants who had physical function decline from before to the end of chemotherapy, 47% recovered by 12 months (were resilient). Almost one‐third experienced functional decline from before chemotherapy to 12 months later. Pretreatment fatigue was a risk factor for functional decline from before to the end of chemotherapy ( P =.02). Risk factors for functional decline at 12 months included pretreatment dyspnea ( P =.007) and being unmarried ( P= .01). Conclusion Functional decline was common in older women receiving adjuvant chemotherapy for breast cancer in a clinical trial. Although half recovered their physical function, one‐third had a clinically meaningful decline at 12 months. Strategies are needed to prevent functional decline in older adults receiving chemotherapy. J Am Geriatr Soc 67:920–927, 2019.
Concerns over Airway Pressure Release Ventilation Management in Children with Acute Respiratory Distress Syndrome
Daxon, Ben, Daxon, Benjamin T.

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | August 27, 2018 | Volume: 198 | Issue: 11 | Pages: 1458-1459

10.1164/rccm.201806-1164le | PMID 30148966 Get It

Amyloidosis: a unifying diagnosis for nephrotic syndrome and congestive cardiac failure
Sara, Jaskanwal Deep Singh , Burton, Mary Caroline, Khodadadi, Ryan, Barth, Dylan , Khodadadi, Ryan B. , Barth, Dylan

Mayo Clinic

BMJ Case Reports | August 27, 2018 | Volume: 2018 | Issue: No issue available | Pages: bcr-2018-224317

10.1136/bcr-2018-224317 | PMID 30150332 Get It

Diagnosing patients simply with heart failure or nephrotic syndrome is insufficient, and clinicians should always search for the underlying causes of these syndromes. Amyloidosis represents a rare group of diseases in which abnormal protein, namely amyloid fibrils, build up in various organs. Presentation depends on which organ systems are involved, and symptoms could include breathlessness associated with fluid overload suggestive of cardiac and/or renal involvement and diarrhoea and weight loss, suggestive of gastrointestinal involvement. The authors present a case of congestive cardiac failure and nephrotic range proteinuria in a patient with persistent fluid overload secondary toamyloid light-chain (AL) amyloidosis.
Effects of the Nasal Muscles on the Nasal Airway
Kienstra, Matthew A., Gassner, Holger G., Sherris, David A., Kern, Eugene B.

Mayo Clinic

American Journal of Rhinology | August 27, 2018 | Volume: 19 | Issue: 4 | Pages: 375-381

10.1177/194589240501900410 Get It

Background The nasal muscles and their function are not clearly defined. The nasal muscles generally are thought to act synergistically to produce mimetic motion and affect the nasal airway. We proposed direct examination of the effects of the nasal muscles on the nasal airway. Methods Rhinomanometry was performed on volunteers. After paralysis of the nasal muscles with lidocaine, rhinomanometry was performed again to measure nasal airway function with the patient at rest and attempting to flare his/her nostrils. Each patient's rhinomanometric results (at rest and attempting to flare the nostrils) taken before injection of lidocaine served as the control for comparison of his/her results postinjection. The structural tension of the ala at rest and with active flaring of the nostril was measured also, and the results pre- and postparalysis with lidocaine were compared. Results The data from both the stiffness (structural tension) and the airflow portions, taken together, support the following conclusions. First, the paralysis was significant, although not complete. Clinical and stiffness data supported complete paralysis. Airflow data, which we think most sensitive, support a statistically significant affect of the injection, although incomplete paralysis. Conclusion All of the evidence supports an important role for the nasal muscles when actively used to increase nasal airflow. Second, the majority of the evidence supports an important resting nasal muscle tension that opens the nasal airway.
Endoscopic Orbital Decompression for Graves’ Ophthalmopathy
Kasperbauer, Jan L. , Hinkley, Lucinda

Mayo Clinic

American Journal of Rhinology | August 27, 2018 | Volume: 19 | Issue: 6 | Pages: 603-606

10.1177/194589240501900613 Get It

Background Graves’ ophthalmopathy generates a volume excess for the orbital cavity, which may produce proptosis, pain, exposure keratitis, diplopia, and optic neuropathy. Endoscopic orbital decompression expands the orbital cavity into the ethmoid cavity and medial maxillary sinus. This retrospective study documents the outcomes after endoscopic orbital decompression for patients with Graves’ ophthalmopathy. Methods Data collected included demographic information, symptom resolution, complications related to the surgery, reduction in proptosis, subsequent need for eye muscle surgery, and hospital length of stay. Between July 1989 and April 2003, 62 patients were referred for endoscopic orbital decompression (often unilateral). Results Three patients refused use of their medical records for research purposes. Seventy percent were women; the average age of the study group was 49 years. Preoperatively, 63% of the patients had diplopia and optic neuropathy was noted in 27%. Two patients had a cerebrospinal fluid leak identified and managed during the decompression. No postoperative leaks occurred. Twenty-five percent of patients did not require eye muscle surgery. Forty-eight percent of the patients underwent one procedure to manage diplopia. The average reduction in proptosis was 2.5 mm. Fifty-four percent were managed as an outpatient and 27% underwent a 23-hour observation period. Conclusion This data supports the safety, efficiency, and efficacy of endoscopic orbital decompression for unilateral and bilateral Graves’ ophthalmopathy. Eye muscle surgery frequently will be required to manage diplopia after decompression. (American Journal of Rhinology 19, 603–606, 2005)
Sinonasal Osteocartilaginous Necrosis in Cocaine Abusers: Experience in 25 Patients
Nicolai, Piero , Lombardi, Davide , Morassi, Maria Laura, Maroldi, Roberto , Gregorini, Gina , Trimarchi, Matteo , Facchetti, Fabio , Specks, Ulrich

Mayo Clinic

American Journal of Rhinology | August 27, 2018 | Volume: 17 | Issue: 1 | Pages: 33-43

10.1177/194589240301700107 Get It

Background Cocaine-induced lesions may cause extensive destruction of the osteocartilaginous structures of the nose, sinuses, and palate that mimics the clinical picture of other diseases. Methods From January 1991 to September 2001 25 patients with cocaine-induced midline destructive lesions were observed at the Department of Otorhinolaryngology of the University of Brescia. The diagnosis was based on physical and endoscopic evaluation, routine blood and urine analysis, radiological findings, and repeated biopsies of the nasal mucosa. Serum was analyzed by the antineutrophilic cytoplasmic antibody (ANCA) test using indirect immunofluorescence and by enzyme-linked immunosorbent assay for antibodies against proteinase 3 and myeloperoxidase. Results Septal perforation was present in all 25 patients, 16 of which (68%) also had partial destruction of the inferior turbinate. Hard palate reabsorption was observed in only six patients (24%); in two of these patients, the lesion also extended to the soft palate. Fourteen patients (56%) were positive by the immunofluorescence test (nine patients had a P-ANCA and five patients a C-ANCA pattern). Four patients (16%) with the P-ANCA pattern and all patients with the C-ANCA pattern also tested positive for anti–proteinase 3 antibodies. Conclusion Any sinonasal inflammation involving the midline that persists or remains refractory to treatment may be the first manifestation of potentially lethal drug addiction. Cocaine abuse should be considered in the differential diagnosis of destructive lesions of the nasal cavity even in the presence of a positive ANCA test.
Antrochoanal Polyps in Children
Orvidas, Laura J. , Beatty, Charles W., Weaver, Amy L.

Mayo Clinic

American Journal of Rhinology | August 27, 2018 | Volume: 15 | Issue: 5 | Pages: 321-325

10.1177/194589240101500507 Get It

Although relatively rare, antrochoanal polyps represent one of the most common types of polyp diagnosed in children without cystic fibrosis. In an attempt to better define this entity and discuss treatment options, the histories and operative reports of all 25 children (aged 17 years and younger) diagnosed with an antrochoanal polyp between 1970 and 1997 at our institution were reviewed. All 25 children complained of nasal obstruction on presentation; other presenting symptoms included rhinorrhea (48%), snoring (36%), and mouth breathing (32%). All 25 patients were noted to have a mass in the nose on examination, and 16 (64%) also had a mass noted in the nasopharynx. All but 1 patient underwent surgical removal of the polyp: intranasal avulsion only, 2 patients; Caldwell-Luc procedures, 10 patients; intranasal procedures, 8 patients; and endoscopic procedures, 4 patients. Mean time to first recurrence was 44.5 months. Seven patients (29%) who underwent excision at our institution experienced recurrence, 3 after endoscopic procedures and 4 after intranasal procedures (with or without Caldwell-Luc; 1 of these patients had a second recurrence). Complications were unusual and included bleeding after pack removal (8.3%) and facial paresthesias (10%). Follow-up ranged from 2 days to almost 27 years and was aided by telephone interviews. We conclude that surgical treatment of these lesions is safe and effective. Endoscopic removal may result in a higher recurrence rate.
Endoscopic Transnasal Pituitary Surgery: Report on 180 Cases
Nasseri, Shawn S., Kasperbauer, Jan L. , Strome, Scott E. , McCaffrey, Thomas V., Atkinson, John L. D., Meyer, Fredric B.

Mayo Clinic

American Journal of Rhinology | August 27, 2018 | Volume: 15 | Issue: 4 | Pages: 281-287

10.1177/194589240101500411 Get It

The endoscopic transnasal approach is an evolving technique for treating lesions in the sella turcica. Since this method was introduced at our institution 4 years ago, the majority of transsphenoidal procedures are performed with it. The records of all patients having endoscopic transnasal hypophysectomy at the Mayo Clinic during the last 4 years were reviewed retrospectively. The criteria analyzed were safety, functional and cosmetic outcome, and complications. During the 4-year period, the operative procedure was modified to improve operative exposure and safety. The results of our review showed a significant decrease in length of hospital stay, reduced operative time, reduced need for nasal packing, and elimination of a sublabial incision. The complication rate was equivalent to that reported for the traditional transseptal transsphenoidal approach. As the neurosurgeons at our institution gained experience with this approach, an increasing number of pituitary microadenomas were resected safely and successfully. In addition, because of the limited septal dissection, this approach is particularly helpful for revision operations. This approach also can be used for the full range of pituitary lesions and in conjunction with adjunctive techniques, including frontal craniotomy and -knife irradiation. Currently, the endoscopic transsphenoidal approach is the method preferred for surgically treating pituitary lesions in adults at our institution.
Value of MRI in medicine: More than just another test?
Kühl, Christiane , Desmond, Patricia , Gong, Qiyong , Gulani, Vikas , Lim, C. C. Tchoyoson , Pipe, James G. , Smits, Marion , Sodickson, Daniel K. , Tempany, Clare M. , Wang, Meiyun , Smits, Marion , Beek, Edwin J.R. van , Anzai, Yoshimi , Ehman, Richard L. , Gold, Garry Evan , Hall-Craggs, Margaret Anne , Leiner, Tim , Reeder, Scott B. , Reinhold, Caroline , Vargas, Hebert Alberto

Mayo Clinic

Journal of Magnetic Resonance Imaging | August 26, 2018 | Volume: 49 | Issue: 7 | Pages: No page available

10.1002/jmri.26211 | PMID 30145852 Get It

There is increasing scrutiny from healthcare organizations towards the utility and associated costs of imaging. MRI has traditionally been used as a high‐end modality, and although shown extremely important for many types of clinical scenarios, it has been suggested as too expensive by some. This editorial will try and explain how value should be addressed and gives some insights and practical examples of how value of MRI can be increased. It requires a global effort to increase accessibility, value for money, and impact on patient management. We hope this editorial sheds some light and gives some indications of where the field may wish to address some of its research to proactively demonstrate the value of MRI.Level of Evidence: 5Technical Efficacy: Stage 5J. Magn. Reson. Imaging 2019;49:e14–e25.
Microbial modulation of the gut microbiome for treating autoimmune diseases
Balakrishnan, Baskar , Taneja, Veena , Balakrishnan, Baskar

Mayo Clinic

Expert Review of Gastroenterology & Hepatology | August 26, 2018 | Volume: 12 | Issue: 10 | Pages: 985-996

10.1080/17474124.2018.1517044 | PMID 30146910 Get It